ArticleJACC. Case reports2026
Transhepatic Access for Transcatheter ASD Closure in Patients With Interrupted IVC.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial septal defect (ASD) is typically managed with percutaneous transcatheter closure via femoral venous access. In patients with interrupted inferior vena cava (IVC), however, conventional access is not feasible. Although the transhepatic approach has been described, it is less frequently utilized. We report 2 patients with secundum ASD and interrupted IVC who underwent successful device closure through transhepatic venous access. Complete closure was obtained in both cases. These cases highlight the feasibility of transhepatic access for ASD closure when femoral access is not possible. Ultrasound guidance and coil embolization of the hepatic tract appear to be important strategies for reducing complications, particularly hemorrhage. One of our patients developed hemoperitoneum requiring emergent laparotomy, whereas the second patient had an uneventful recovery. Transhepatic access provides a valuable alternative route for percutaneous ASD closure in patients with interrupted IVC, and it can expand therapeutic options for structurally complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.